Literature DB >> 23212997

Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.

Michel G Khouri1, Pamela S Douglas, John R Mackey, Miguel Martin, Jessica M Scott, Marielle Scherrer-Crosbie, Lee W Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23212997      PMCID： PMC3667651          DOI： 10.1161/CIRCULATIONAHA.112.100560

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  144 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial.

Authors:  Lee W Jones; Kerry S Courneya; Adrian S Fairey; John R Mackey
Journal:  Ann Behav Med       Date:  2004-10

3.  Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.

Authors:  Michael S Ewer; Scott M Lippman
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

Review 4.  Is cardiotoxicity being adequately assessed in current trials of cytotoxic and targeted agents in breast cancer?

Authors:  S Verma; M S Ewer
Journal:  Ann Oncol       Date:  2010-11-22       Impact factor: 32.976

5.  A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin.

Authors:  M S Ewer; M K Ali; B Mackay; S Wallace; M Valdivieso; S S Legha; R S Benjamin; T P Haynie
Journal:  J Clin Oncol       Date:  1984-02       Impact factor: 44.544

6.  Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.

Authors:  Daniela Cardinale; Alessandro Colombo; Maria T Sandri; Giuseppina Lamantia; Nicola Colombo; Maurizio Civelli; Giovanni Martinelli; Fabrizio Veglia; Cesare Fiorentini; Carlo M Cipolla
Journal:  Circulation       Date:  2006-11-13       Impact factor: 29.690

7.  Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.

Authors:  Henning Mouridsen; Aparna Keshaviah; Alan S Coates; Manuela Rabaglio; Monica Castiglione-Gertsch; Zhuoxin Sun; Beat Thürlimann; Louis Mauriac; John F Forbes; Robert Paridaens; Richard D Gelber; Marco Colleoni; Ian Smith; Karen N Price; Aron Goldhirsch
Journal:  J Clin Oncol       Date:  2007-11-12       Impact factor: 44.544

8.  Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy.

Authors:  D L Santos; A J M Moreno; R L Leino; M K Froberg; K B Wallace
Journal:  Toxicol Appl Pharmacol       Date:  2002-12-15       Impact factor: 4.219

9.  Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells.

Authors:  Neil L Spector; Yosef Yarden; Bradley Smith; Ljuba Lyass; Patricia Trusk; Karen Pry; Jason E Hill; Wenle Xia; Rony Seger; Sarah S Bacus
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-07       Impact factor: 11.205

10.  Doxorubicin directly binds to the cardiac-type ryanodine receptor.

Authors:  Kazuhiko Saeki; Ichiro Obi; Noriko Ogiku; Munekazu Shigekawa; Toshiaki Imagawa; Takeshi Matsumoto
Journal:  Life Sci       Date:  2002-04-05       Impact factor: 5.037
View more
  63 in total

Review 1.  Cardiotoxicity due to chemotherapy: role of cardiac imaging.

Authors:  Frédéric Poulin; Paaladinesh Thavendiranathan
Journal:  Curr Cardiol Rep       Date:  2015-03       Impact factor: 2.931

Review 2.  Update on the Treatment of Early-Stage Triple-Negative Breast Cancer.

Authors:  Priyanka Sharma
Journal:  Curr Treat Options Oncol       Date:  2018-04-14

3.  [Overweight and obesity are risk factors for development of cardiotoxicity from anthracyclines or sequential administration of anthracyclines and trastuzumab].

Authors:  Martin Wilhelm
Journal:  Strahlenther Onkol       Date:  2017-03       Impact factor: 3.621

4.  Prolonged electromechanical delay as an early predictor of trastuzumab-induced cardiotoxicity in patients undergoing treatment for breast cancer.

Authors:  Jeong Cheon Choe; Jung Hyun Choi; Jong Hyun Choi; Jinhee Ahn; Jin Sup Park; Hye Won Lee; Jun-Hyok Oh; Han Cheol Lee; Kwang Soo Cha; Taek Jong Hong
Journal:  Clin Cardiol       Date:  2018-10-16       Impact factor: 2.882

5.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A Sebag; Deborah A Agler; Luigi P Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M DeCara; Thor Edvardsen; Scott D Flamm; Thomas Force; Brian P Griffin; Guy Jerusalem; Jennifer E Liu; Andreia Magalhães; Thomas Marwick; Liza Y Sanchez; Rosa Sicari; Hector R Villarraga; Patrizio Lancellotti
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-10       Impact factor: 6.875

6.  Cardiac complications of chemotherapy: role of prevention.

Authors:  Laura Carola Magnano; Nuria Martínez Cibrian; Xavier Andrade González; Xavier Bosch
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-06

7.  Effects of Exercise Therapy Dosing Schedule on Impaired Cardiorespiratory Fitness in Patients With Primary Breast Cancer: A Randomized Controlled Trial.

Authors:  Jessica M Scott; Samantha M Thomas; Jeffrey M Peppercorn; James E Herndon; Pamela S Douglas; Michel G Khouri; Chau T Dang; Anthony F Yu; Diane Catalina; Cristi Ciolino; Catherine Capaci; Meghan G Michalski; Neil D Eves; Lee W Jones
Journal:  Circulation       Date:  2020-02-17       Impact factor: 29.690

Review 8.  Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.

Authors:  Vinisha Garg; Gabriel Vorobiof
Journal:  Curr Oncol Rep       Date:  2016-08       Impact factor: 5.075

Review 9.  Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Charles Guenancia; Annick Lefebvre; Daniela Cardinale; Anthony F Yu; Sylvain Ladoire; François Ghiringhelli; Marianne Zeller; Luc Rochette; Yves Cottin; Catherine Vergely
Journal:  J Clin Oncol       Date:  2016-07-25       Impact factor: 44.544

10.  Managing cardiotoxicity of chemotherapy.

Authors:  Alessandro Colombo; Carlo A Meroni; Carlo M Cipolla; Daniela Cardinale
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.